Piqur Therapeutics' Series A Round

Piqur Therapeutics raised a round of funding on January 21, 2014.

PIQUR is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs based on lipid kinase (PI3K) and mTOR inhibition. PIQUR's pipeline originates from one of the mos…

Articles about Piqur Therapeutics' Series A Round: